Metropolis Healthcare Ltd
NSE:METROPOLIS
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Metropolis Healthcare Ltd
NSE:METROPOLIS
|
IN |
|
Sumitomo Forestry Co Ltd
TSE:1911
|
JP |
|
ImExHS Ltd
ASX:IME
|
AU |
|
F
|
Fast Accounting Co Ltd
TSE:5588
|
JP |
|
N4 Pharma PLC
LSE:N4P
|
UK |
|
Beyondspring Inc
NASDAQ:BYSI
|
US |
|
China Longyuan Power Group Corp Ltd
HKEX:916
|
CN |
|
T
|
Teladan Setia Group Bhd
KLSE:TELADAN
|
MY |
Wall Street
Price Targets
METROPOLIS Price Targets Summary
Metropolis Healthcare Ltd
According to Wall Street analysts, the average 1-year price target for
METROPOLIS
is 578.07 INR
with a low forecast of 448.19 INR and a high forecast of 714.26 INR.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is METROPOLIS's stock price target?
Price Target
578.07
INR
According to Wall Street analysts, the average 1-year price target for
METROPOLIS
is 578.07 INR
with a low forecast of 448.19 INR and a high forecast of 714.26 INR.
What is Metropolis Healthcare Ltd's Revenue forecast?
Projected CAGR
17%
For the last 8 years the
compound annual growth rate for
Metropolis Healthcare Ltd's revenue is
12%.
The projected
CAGR
for the next 4 years is
17%.
What is Metropolis Healthcare Ltd's Operating Income forecast?
Projected CAGR
28%
For the last 8 years the
compound annual growth rate for
Metropolis Healthcare Ltd's operating income is
5%.
The projected
CAGR
for the next 3 years is
28%.
What is Metropolis Healthcare Ltd's Net Income forecast?
Projected CAGR
29%
For the last 8 years the
compound annual growth rate for
Metropolis Healthcare Ltd's net income is
5%.
The projected
CAGR
for the next 3 years is
29%.
